We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+9.41%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$1.27B
AUM Growth
+$102M
Cap. Flow
+$13.4M
Cap. Flow %
1.05%
Top 10 Hldgs %
34.43%
Holding
2,813
New
122
Increased
1,063
Reduced
999
Closed
97

Sector Composition

Rank Sector Weight
1 Technology 15.34%
2 Financials 8.08%
3 Healthcare 7.07%
4 Consumer Staples 6.48%
5 Consumer Discretionary 6.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPWR
2501
DELISTED
SunPower Corporation Common Stock
SPWR
$2.09K ﹤0.01%
698
-4,876
-87% -$16.1K
PRLB icon
2502
Protolabs
PRLB
$1.85B
$2.07K ﹤0.01%
58
BE icon
2503
Bloom Energy
BE
$53.5B
$2.04K ﹤0.01%
+181
New +$1.99K
KNTK icon
2504
Kinetik
KNTK
$3.59B
$2.03K ﹤0.01%
51
+32
+168% +$1.1K
ABCL icon
2505
AbCellera Biologics
ABCL
$1.6B
$2.03K ﹤0.01%
448
-1,555
-78% -$7.93K
PSEC icon
2506
Prospect Capital
PSEC
$1.12B
$2.02K ﹤0.01%
366
XMTR icon
2507
Xometry
XMTR
$4.75B
$2.01K ﹤0.01%
119
CLBK icon
2508
Columbia Financial
CLBK
$1.13B
$2K ﹤0.01%
116
EGBN icon
2509
Eagle Bancorp
EGBN
$858M
$2K ﹤0.01%
85
BILL icon
2510
BILL Holdings
BILL
$4.47B
$1.99K ﹤0.01%
29
-42
-59% -$2.94K
VERV
2511
DELISTED
Verve Therapeutics
VERV
$1.99K ﹤0.01%
150
FLNA
2512
Filana Therapeutics
FLNA
$43.5M
$1.99K ﹤0.01%
98
PACB icon
2513
Pacific Biosciences
PACB
$422M
$1.98K ﹤0.01%
+529
New +$3.1K
FBP icon
2514
First Bancorp
FBP
$4.39B
$1.98K ﹤0.01%
113
ENVX icon
2515
Enovix
ENVX
$923M
$1.98K ﹤0.01%
282
-1,814
-87% -$15.8K
RVNC
2516
DELISTED
Revance Therapeutics, Inc.
RVNC
$1.97K ﹤0.01%
400
-198
-33% -$1.17K
DNB
2517
DELISTED
Dun & Bradstreet
DNB
$1.94K ﹤0.01%
193
UDMY
2518
DELISTED
Udemy
UDMY
$1.93K ﹤0.01%
176
+135
+329% +$1.68K
SCHO icon
2519
Schwab Short-Term US Treasury ETF
SCHO
$12.8B
$1.93K ﹤0.01%
80
CBAN icon
2520
Colony Bankcorp
CBAN
$460M
$1.92K ﹤0.01%
+167
New +$1.97K
NARI
2521
DELISTED
Inari Medical, Inc. Common Stock
NARI
$1.92K ﹤0.01%
40
-2
-5% -$107
DSGR icon
2522
Distribution Solutions Group
DSGR
$1.6B
$1.92K ﹤0.01%
54
-100
-65% -$3.21K
ADPT icon
2523
Adaptive Biotechnologies
ADPT
$3.61B
$1.89K ﹤0.01%
+589
New +$2.28K
SFL icon
2524
SFL Corp
SFL
$1.59B
$1.89K ﹤0.01%
+143
New +$1.8K
IHRT icon
2525
iHeartMedia
IHRT
$547M
$1.88K ﹤0.01%
900

Similar funds

Quadrant Capital Group's Q1 2024 Portfolio in Review

As of Q1 2024, Quadrant Capital Group held 2,813 positions worth $1.27B, up 8.8% from $1.16B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Quadrant Capital Group's Q1 2024 filing shows 122 new, 1,063 increased, 999 reduced and 97 closed positions. Its largest new stake was GRIID Infrastructure Inc. Common Stock: 1,465,728 shares worth $1.93M. The largest sale was iShares Global Infrastructure ETF, an estimated $3.78M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • Quadrant Capital Group's largest Q1 2024 buy was GRIID Infrastructure Inc. Common Stock: 1,465,728 shares worth $1.93M.
  • Quadrant Capital Group added most to JPMorgan Ultra-Short Income ETF in Q1 2024, an estimated $8.28M increase.
  • Quadrant Capital Group's biggest Q1 2024 reduction was iShares Global Infrastructure ETF, cutting an estimated $3.78M.
  • Quadrant Capital Group fully exited INmune Bio in Q1 2024, selling an estimated $676K.
  • Quadrant Capital Group's ten largest holdings make up 34% of its $1.27B portfolio in Q1 2024.
  • Quadrant Capital Group opened 122 new positions and closed 97 in Q1 2024.
  • Quadrant Capital Group's portfolio value rose 8.8% quarter-over-quarter to $1.27B.

Based on Quadrant Capital Group's 13F filing for Q1 2024, filed 15 May 2024.